Multiple Manufacturers

CELLCEPT - IV

Manufacturer:

Multiple Manufacturers

Cellcept - Iv HCPCS:

J7519

HCPCS Code Descriptor:

Injection, mycophenolate mofetil, 10 mg

Category:

J Code

Cellcept - Iv NDCs:

17478-0957-40, 67457-0386-81, 42023-0172-04, 71288-0803-21, 17478-0422-40, 00004-0298-09

Primary Type:

Immunosuppressant

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

17478-0957-40, 67457-0386-81, 42023-0172-04, 71288-0803-21, 17478-0422-40, 00004-0298-09

About Cellcept - Iv:

CELLCEPT - IV is a medication manufactured by multiple manufacturers and aligned to the J Code: J7519. CELLCEPT - IV is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J7519 Added Date:

October 1, 2023

J7519 Effective Date:

October 1, 2023

J7519 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cellcept – Iv billing and coding information.
Cellcept – Iv patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-support-services
CELLCEPT – IV prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for CELLCEPT – IV. Please check back in a few weeks.